132 related articles for article (PubMed ID: 16305379)
1. Passive and iontophoretic controlled delivery of salmon calcitonin through artificial membranes.
Stamatialis DF; Rolevink HH; Koops GH
Curr Drug Deliv; 2004 Apr; 1(2):137-43. PubMed ID: 16305379
[TBL] [Abstract][Full Text] [Related]
2. Controlled transport of timolol maleate through artificial membranes under passive and iontophoretic conditions.
Stamatialis DF; Rolevink HH; Koops GH
J Control Release; 2002 Jun; 81(3):335-45. PubMed ID: 12044572
[TBL] [Abstract][Full Text] [Related]
3. Drug reservoir composition and transport of salmon calcitonin in transdermal iontophoresis.
Santi P; Colombo P; Bettini R; Catellani PL; Minutello A; Volpato NM
Pharm Res; 1997 Jan; 14(1):63-6. PubMed ID: 9034222
[TBL] [Abstract][Full Text] [Related]
4. The effect of electroporation on iontophoretic transdermal delivery of calcium regulating hormones.
Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
J Control Release; 2000 May; 66(2-3):127-33. PubMed ID: 10742574
[TBL] [Abstract][Full Text] [Related]
5. Transdermal iontophoretic delivery of salmon calcitonin.
Chang SL; Hofmann GA; Zhang L; Deftos LJ; Banga AK
Int J Pharm; 2000 Apr; 200(1):107-13. PubMed ID: 10845691
[TBL] [Abstract][Full Text] [Related]
6. In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin.
Chaturvedula A; Joshi DP; Anderson C; Morris RL; Sembrowich WL; Banga AK
Int J Pharm; 2005 Jun; 297(1-2):190-6. PubMed ID: 15907605
[TBL] [Abstract][Full Text] [Related]
7. Transdermal iontophoresis of salmon calcitonin can reproduce the hypocalcemic effect of intravenous administration.
Santi P; Volpato NM; Bettini R; Catellani PL; Massimo G; Colombo P
Farmaco; 1997; 52(6-7):445-8. PubMed ID: 9372596
[TBL] [Abstract][Full Text] [Related]
8. Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats.
Morimoto K; Iwakura Y; Nakatani E; Miyazaki M; Tojima H
J Pharm Pharmacol; 1992 Mar; 44(3):216-8. PubMed ID: 1354726
[TBL] [Abstract][Full Text] [Related]
9. In vivo iontophoretic delivery of salmon calcitonin across microporated skin.
Vemulapalli V; Bai Y; Kalluri H; Herwadkar A; Kim H; Davis SP; Friden PM; Banga AK
J Pharm Sci; 2012 Aug; 101(8):2861-9. PubMed ID: 22644951
[TBL] [Abstract][Full Text] [Related]
10. Transdermal administration of salmon calcitonin by pulse depolarization-iontophoresis in rats.
Nakamura K; Katagai K; Mori K; Higo N; Sato S; Yamamoto K
Int J Pharm; 2001 May; 218(1-2):93-102. PubMed ID: 11337153
[TBL] [Abstract][Full Text] [Related]
11. Iontophoresis-based transdermal delivery systems.
Kanikkannan N
BioDrugs; 2002; 16(5):339-47. PubMed ID: 12408738
[TBL] [Abstract][Full Text] [Related]
12. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
13. Hydrogel-based iontotherapeutic delivery devices for transdermal delivery of peptide/protein drugs.
Banga AK; Chien YW
Pharm Res; 1993 May; 10(5):697-702. PubMed ID: 8321834
[TBL] [Abstract][Full Text] [Related]
14. Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics.
Zhang L; Li Y; Wei F; Liu H; Wang Y; Zhao W; Dong Z; Ma T; Wang Q
AAPS PharmSciTech; 2020 Nov; 22(1):1. PubMed ID: 33215299
[TBL] [Abstract][Full Text] [Related]
15. Transdermal iontophoretic drug delivery: advances and challenges.
Ita K
J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
[TBL] [Abstract][Full Text] [Related]
16. To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber.
Xin C; Lihong W; Fei H; Yan W; Qifang W; Yang Y; Yue Y; San-ming L
Drug Dev Ind Pharm; 2014 Jan; 40(1):9-16. PubMed ID: 23317337
[TBL] [Abstract][Full Text] [Related]
17. Iontophoretic enhancement of timolol across human dermatomed skin in vitro.
Fatouros DG; Bouwstra JA
J Drug Target; 2004 Jan; 12(1):19-24. PubMed ID: 15203908
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of a hydroxypropyl cellulose gel system for transdermal delivery of timolol.
Stamatialis DF; Rolevink HH; Gironès M; Nymeijer DC; Koops GH
Curr Drug Deliv; 2004 Oct; 1(4):313-9. PubMed ID: 16305393
[TBL] [Abstract][Full Text] [Related]
19. Transdermal iontophoretic drug delivery: mechanistic analysis and application to polypeptide delivery.
Srinivasan V; Higuchi WI; Sims SM; Ghanem AH; Behl CR
J Pharm Sci; 1989 May; 78(5):370-5. PubMed ID: 2664125
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
